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Six networkWhile the signaling pathways and transcription factors active in adult slow- and fast-type muscles begin to
be characterized, genesis of muscle ﬁber-type diversity during mammalian development remains
unexplained.
We provide evidence showing that Six homeoproteins are required to activate the fast-type muscle program
in the mouse primary myotome. Affymetrix transcriptomal analysis of Six1−/−Six4−/− E10.5 somites
revealed the speciﬁc down-regulation of many genes of the fast-type muscle program. This data was
conﬁrmed by in situ hybridization performed on Six1−/−Six4−/− embryos. The ﬁrst mouse myocytes express
both fast-type and slow-type muscle genes. In these ﬁbers, Six1 and Six4 expression is required to
speciﬁcally activate fast-type muscle genes. Chromatin immunoprecipitation experiments conﬁrm the
binding of Six1 and Six4 on the regulatory regions of these muscle genes, and transfection experiments show
the ability of these homeoproteins to activate speciﬁcally identiﬁed fast-type muscle genes.
This in vivo wide transcriptomal analysis of the function of the master myogenic determinants, Six, identiﬁes
them as novel markers for the differential activation of a speciﬁc muscle program during mammalian somitic
myogenesis.
© 2009 Elsevier Inc. All rights reserved.Introduction
Adult skeletal muscles in mammals are composed of different ﬁber
types that express speciﬁc isoforms of contractile proteins and
metabolic enzymes. Two broad classes of muscle ﬁbers have been
deﬁned: slow-type oxidative ﬁbers that are fatigue resistant and fast-
type glycolytic ﬁbers recruited for brief and intense efforts that are not
fatigue resistant. The mechanisms that participate in the adult muscle
phenotype have been well characterized. Slow- and fast-type
motorneurons induce differential intracellular calcium concentration
oscillations in slow- and fast-type myoﬁbers, respectively (Olson and
Williams, 2000). Different signaling pathways are activated by these
intracellular calcium concentrations. The calcineurin phosphatase,
which modulates NFAT nucleo-cytoplasmic localization and activates
the transcription factors MEF2, triggers the slow/oxidative phenotype
(Chin et al., 1998; Shen et al., 2006; Tothova et al., 2006; Wu et al.,
2001). The calcium-dependent CaM kinase controls the slow/
oxidative phenotype by activating MEF2 transcription factors throughGénétique et Développement,
ll rights reserved.the speciﬁc phosphorylation and degradation of HDAC proteins in
slow-type ﬁbers (Chin, 2005; Kim et al., 2008; Potthoff et al., 2007;
Wu et al., 2002). PPARδ (Schuler et al., 2006) and PGC1α (Lin et al.,
2002) also participate in triggering the slow/oxidative adult muscle
phenotype. Less is known about signaling pathways and transcription
factors responsible for the fast/glycolytic phenotype. A link between
slow-typemotorneuron activity and higher phosphorylation of MyoD,
preventing its binding to DNA, has been established. MyoD is thus able
to activate gene transcription only in fast-type myoﬁbers (Ekmark et
al., 2007). Activated phospho-Erk2 accumulates more in fast-type
ﬁbers compared to slow-type ﬁbers, and forced positive transdomi-
nant Erk2 expression in the adult myoﬁber is able to induce a slow to
fast phenotype transformation (Shi et al., 2008). We have shown that
the Six1 homeoprotein and its Eya1 cofactor accumulate to a higher
level in the nuclei of the fast-type gastrocnemius muscle compared to
those of the slow-type soleus muscle. In addition, forced expression of
these two proteins in the soleus ﬁbers was able to change their slow/
oxidative phenotype to a fast/glycolytic phenotype (Grifone et al.,
2004). The higher activity of the Six transcriptional complex (STC) in
the fast/glycolytic ﬁbers has been previously demonstrated (Grifone
et al., 2004; Spitz et al., 1997); however, the mechanisms controlling
resting levels of Six1 and Eya1 in the nuclei of fast and slow-type
Fig. 1. The myotome of E10.5 SixdKO embryos is severely reduced. Immunohistochem-
istry using antibodies against Desmin on transverse sections of E10.5 Six1−/+Six4−/+
(A) and Six1−/−Six4−/− (A′) embryos at the interlimb level. The dorsal aspect of the
sections is up, the ventral aspect is down. Quantiﬁcation of Desmin staining area in
E10.5 control and SixdKO embryos (B). Quantiﬁcation of 13 sections from four control
and four SixdKO embryos at the interlimb level, error bars indicate standard deviation.
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type ﬁbers is an early event: in 5-day-old animals the aldolase A
promoter is already active by more than 10-fold in the gastrocnemius
than in the soleus (Spitz et al., 1999). This suggests that the STC
activity may have a precocious role in the activation of a fast-type
myogenic program during development rather than relying on slow/
fast differential motorneuron activity, which takes place later during
post-natal development (Bewick et al., 2004).
Six1 and Six4 genes are also expressed during embryogenesis, and
we have shown that Six1−/−Six4−/− (SixdKO) fetuses have a severe
muscle phenotype characterized by the absence of limb and trunk
hypaxial muscles (Grifone et al., 2005). Epaxial back muscles are the
only remaining axial muscles present in E18.5 SixdKO fetuses. We
have previously shown that Six homeoproteins control hypaxial
myogenesis by two mechanisms. First, Six proteins and their Eya
cofactors are required for the expression of Pax3 in the ventrolateral
lip of the dermomyotome in the mouse embryo, controlling the
genesis of hypaxial myogenic progenitors (Grifone et al., 2007, 2005).
In SixdKO embryos, myogenic progenitors primarily arise from the
posterior and anterior lip of the dermomyotome, where Pax3
expression is not under the control of Six1/4 proteins, and from the
early epaxial lip of the dermomyotome at the onset ofMyf5 activation
at E8.5 (Grifone et al., 2007, 2005), when epaxial Myf5 expression is
not under the control of Pax3 or Pax7 (Relaix et al., 2005). These
progenitors give rise to a primary myotome which is shortened in its
ventral region in the mutant embryos. Second, Six proteins are
required for the somitic expression of Mrf4 and myogenin (Grifone et
al., 2005). Whether Six1 and Six4 genes also have a role in the mouse
early myotome to speciﬁcally activate a fast-type muscle program has
not yet been established. The emergence of fast/slow ﬁber-type
diversity during mammalian development is poorly understood. The
mechanisms involved in adult ﬁber-type specialization have not been
shown to participate in the genesis of muscle ﬁber-type diversity
during embryonic or fetal myogenesis to date. Genesis of ﬁber-type
diversity has been well studied in zebraﬁsh, where different
populations of slow and fast-type myogenic progenitors have been
characterized. It has been shown that Blimp1/Prdm1, a transcrip-
tional repressor induced in response to Hh signaling, directs the
differentiation of adaxial cells towards the slow lineage. Blimp1/
Prdm1 promotes slow-type differentiation by directly acting as a
global repressor of fast-type muscle genes and by inhibiting the
transcription of Sox6, a repressor of slow-type gene transcription
(Baxendale et al., 2004; Hagiwara et al., 2007; Liew et al., 2008; von
Hofsten et al., 2008). On the other hand FGF8 drives the differentiation
of lateral fast-type ﬁbers under the control of retinoic acid (Groves et
al., 2005; Hamade et al., 2006) and this mechanism seems to be
relayed by Pbx and MyoD (Maves et al., 2007). The signiﬁcance of
these signaling pathways in modulating the behavior of myogenic
progenitors in amniotes has not yet been established. Both Hh and
Blimp1/Prdm1 are expressed in the mouse embryo but their ability to
inﬂuence the slow/fast phenotype of somitic myogenic progenitors
has not been demonstrated to date. In the chick embryo, the primary
myotome expresses both fast/embryonic and slow myosin heavy
chains, with no evidence of ﬁber-type heterogeneity in the myocyte
population (Sacks et al., 2003). Later in the development of the chick
embryo, the tissues surrounding nascent myoﬁbers play instructive
roles in their slow/fast differentiation (Robson and Hughes, 1999).
Such an instructive role of the environment on naïve myogenic
progenitors has also been elegantly illustrated by monitoring the
behavior of somitic myogenic progenitors in the limb buds of chick
embryos, showing that these somitic progenitors were not instructed
in their later slow/fast differentiation program (Kardon et al., 2002).
The Wnt family of secreted molecules are good candidates for
inﬂuencing ﬁber-type differentiation. Wnt5a promotes slow ﬁber
differentiation at the expense of fast ﬁber differentiation, whereas
Wnt11 has the opposite effect (Anakwe et al., 2003). On the otherhand, several studies indicate thatmyogenic progenitors are endowed
with speciﬁc fast, slow or slow/fast potential, that is clonally heritable
(DiMario et al., 1993; Pin et al., 2002), and that myogenic cells are
instructed in the somite to differentiate as slow- or fast-type
myoﬁbers (Nikovits et al., 2001). No genetic marker has yet been
characterized in amniotes that identiﬁes these populations. However,
Sox6 null mouse embryos show an up-regulation of slow-type muscle
gene expression only after E15, arguing for a conserved role of Sox6
between zebraﬁsh and mouse fetal myogenesis for the acquisition of
the fast-type phenotype (Hagiwara et al., 2007).
To characterize the primary defects observed in the somites of
SixdKO embryos, we compared their transcriptome to that of control
embryos using Affymetrix microarray technology. In this report, we
show that Six1 and Six4 are required to activate a network of fast-type
muscle genes in mixed slow/fast myocytes of the primary myotome.
We further provide evidence that Pax3 expression in hypaxial
myogenic progenitors of the dermomyotome is dispensable in
achieving this speciﬁc activation. Mrf4 and Myogenin, two Muscle
Regulatory Factors whose early somitic expression is under the
control of Six proteins, are also dispensable for myotomal fast-type
muscle gene expression. Last, by chromatin immunoprecipitation
experimentswe show direct binding of Six1 and Six4 to the regulatory
regions of the identiﬁed muscle genes, arguing for a direct control of
their expression by Six homeoproteins.
Results
Fast-type muscle genes are speciﬁcally down-regulated in SixdKO embryos
As previously described (Grifone et al., 2005) the myotome of
SixdKO is reduced to the central region of the somite in the E10.5
mouse embryo. To characterize the myotome, we ﬁrst evaluated its
size by immunohistochemistry with Desmin antibodies (Fig. 1): the
myotome of SixdKO embryos (Fig. 1A′) is severely reduced compared
170 C. Niro et al. / Developmental Biology 338 (2010) 168–182to control embryos (Fig. 1A). Desmin immunostaining area is reduced
by 47% (±6.5%) in SixdKO compared to control embryos (Fig. 1B). This
reduction reﬂects the reduced number of myocytes present in the
primary myotome of SixdKO embryos.
To deﬁne the network of genes under the control of the Six
transcriptional complexes (STC) during muscle development, we
aimed to compare the transcriptome of control and SixdKO E10.5
embryos. For that purpose, E10.5 embryos were eviscerated, and the
neural tube, the limbs and the head were discarded. RNA was then
prepared from the remaining axial tissues and was hybridized on
Affymetrix microarrays. According to the reduced size of the
myotome in SixdKO embryos, the expression of most muscle genes
is down-regulated. This is the case for titin, an early structural gene of
the myotome, whose expression is down-regulated 2.2-fold in SixdKO
embryos (data not shown). To identify relevant genes under the
transcriptional control of Six proteins, we focused our analysis on
genes whose expression was down-regulated by at least 3-fold in
SixdKO embryos. The down-regulation of muscle genes by more
than 3-fold is assumed to be the consequence of their direct down-
regulation in remaining myocytes rather than the consequence of the
reduced size of the myotome. Those genes not expressed or down-
regulated by more than 3-fold in SixdKO embryos as compared to
control embryos are listed in Table 1. As shown in Table 1, Six4
expression is not detected in SixdKO embryos as expected. However,
the Six1 Affymetrix probe is localized to the second exon of the Six1
gene, which is present in the SixdKO genome (Laclef et al., 2003),
explaining why the Affymetrix Six1 probe is still detected. Myogenin,
known to be under the control of Six proteins in the myotome
(Grifone et al., 2005), is down-regulated 4.8-fold in SixdKO embryos.
Mrf4, whose expression is not detected in E9.5–E10.5 SixdKO embryos
(Grifone et al., 2005), is also not detected in the control samples in the
present Affymetrix microarray analysis. Most of the genes identiﬁed
by the present Affymetrix experiment are expressed in the post-
mitotic myocytes present in themouse primarymyotome.We noticed
the down-regulation of many structural muscle genes in SixdKO
embryos, for example, Acta1 and Mybph. An important number of
fast-type muscle genes are also down-regulated in SixdKO embryos,
reminiscent of the known role of Six genes in the adult fast/glycolyticTable 1
Genes down-regulated more than 3-fold in E10.5 SixdKO embryos. Affymetrix micro-
arrays analysis. FC: Fold Change=control/SixdKO, nd=not detected in SixdKO embryos.
Fast-type muscle genes are in gray.
lphenotype (Grifone et al., 2004). This is the case for Tnnc2, Tnnt3 and
Atp2a1, whose expression is not detected in mutant embryos, and for
Myh3, Myl1,Mylpf, and Eno3,whose expression is strongly diminished.
Only one slow-type muscle gene, Tnnc1, in which a Six binding site
(MEF3 site) has been originally described in its skeletal enhancer
(Parmacek et al., 1994), is down-regulated more than three fold in
SixdKO embryos.
We conﬁrmed the Affymetrix data by analyzing the expression
of fast-type genes by in situ hybridization (Fig. 2). The expression of
fast-type muscle genes (Atp2a1, Myl1, Mylpf, Tnnt3 and Tnnc2) is
not detected in E10.5 SixdKO embryos (Figs. 2A–E, A′–E′), while
MyHCemb/Myh3 is still detected in SixdKO embryos (data not
shown). We also analyzed the expression of the fast-type gene
sarcalumenin Srl expressed in the somitic myocytes (Zhao et al.,
2005). As for the other fast-type muscle genes, its expression is not
detected in SixdKO embryos (Figs. 2F and F′).
To conﬁrm that the absence of fast-type muscle genes expression
in SixdKO was not due to a global differentiation defect, we analyzed
the expression of genes encoding proteins speciﬁc of the slow-type
muscle ﬁber. The expression of all slow-type muscle genes tested
was maintained in the remaining myotome present in the SixdKO
embryos, except for Tnnc1 (data not shown). This is true for myosin
light polypeptide 6B Myl6b, myosin light polypeptide 4 Myl4, troponin
T1 skeletal slow Tnnt1 and troponin I skeletal slow, 1 Tnni1 (Figs. 2G–J,
G′–J′). We also observed that Blimp1/Prdm1, whose expression is
restricted in slow adaxial cells in zebraﬁsh, is still expressed in
SixdKO embryos (Figs. 2K, K′). In addition, expression of vestigial like
2 homolog (Drosophila) Vito1, a cofactor of MEF2 and MCAT
transcription factors, whose expression is higher in adult slow-type
myoﬁbers than in adult fast-type myoﬁbers (A. Guernec, P.M,
unpublished; Mielcarek et al., 2002) is also maintained (Figs. 2L, L′).
Because the classiﬁcation of muscle ﬁber types is deﬁned by the
expression of MyHC (Myosin Heavy Chain) isoforms, we analyzed the
expression of the MyHC slow (MyHCs) in the myotome of SixdKO
embryos (Figs. 3A–B and A′–B′). Its expression is still detected in
SixdKO myotome. The percentage of the myotome area positive for
both Desmin and MyHCs is comparable between E10.5 control (68.8±
7.6%) and SixdKO (58.6±9.5%) embryos, conﬁrming that the slow
program is maintained in mutant embryos (Fig. 3C).
We conclude that Six proteins are required to activate the
expression of many fast-type muscle genes in the mouse primary
myotome. These data also indicate that the expression pattern of the
fast-type and slow-type muscle genes analyzed in control embryos is
not restricted to speciﬁc sub-myotomal regions. All myocytes,
whatever their hypaxial, epaxial, anterior or posterior dermomyo-
tomal lip origins, seem to activate the same battery of slow- and
fast-type muscle genes, as analyzed by in situ hybridization (see also
Fig. 4).
Fast-type and slow-type muscle proteins are co-expressed in the primary
mouse myotome
In situ hybridization data support a role for Six1/4 homeoproteins
in activating the muscle fast-type program in the myocytes of the
primary myotome. However, they did not allow us to determine
whether the myocytes express both fast-type and slow-type proteins.
To answer this question we checked the accumulation of structural
proteins in the myotomal ﬁbers using immunoﬂuorescence. The fast
Atp2a1 protein is co-expressed with the slow Tnni1 protein (Figs. 4A
and A′, B and B′) and with the fast Tnnt3 protein (data not shown).
Furthermore, all the myocytes expressing MyHCemb also express
MyHCs (data not shown). Thus, fast-type muscle proteins, identiﬁed
as Six targets, and slow-type muscle proteins are co-expressed in the
same myocytes. Our results extend previous data obtained with the
detection of other slow-type (Myosin heavy chain I) and fast-type
markers (embryonic Myosin heavy chain) that showed co-expression
Fig. 2. Fast-type muscle genes are speciﬁcally down-regulated in SixdKO embryos. Whole mount in situ hybridization of Six1−/+Six4−/+ (A–L) and Six1−/−Six4−/− (A′–L′) E10.5
embryos. Fast-type muscle genes: Atp2a1, Myl1, Mylpf, Tnnt3, Tnnc2 and Srl are no longer detected in Six1−/−Six4−/− embryos (A–F and A′–F′). Slow-type muscle genes: Myl6b,
Myl4, Tnnt1, Tnni1, Prdm1 and Vito1 are still expressed in the remaining myotome of these mutants (G–L and G′–L′). Arrowheads pinpoint the somitic expression of the slow-type
muscle genes in SixdKO embryos.
171C. Niro et al. / Developmental Biology 338 (2010) 168–182of these proteins in the chick primary myotome (Sacks et al., 2003).
We also show that Six1 and Six4 proteins not only accumulate in the
nuclei of myogenic progenitors present in the dermomyotomal lips, as
previously described (Grifone et al., 2005), but also in the nuclei
present in E10.5 myocytes. Nuclear Six1 protein is detected in all the
myocytes expressing Myogenin and in all the myocytes expressing
Atp2a1 (Figs. 4D–E). As all the myocytes expressing Atp2a1 express
Tnni1 we conclude that all the myocytes coexpress Atp2a1 and Tnni1
with Six1. Six4 nuclear accumulation is also detected in all the
myocytes expressing Atp2a1 (Fig. 4F). Thus, it appears that Six1 and
Six4 proteins are present in mixed fast/slow myocytes of the primary
myotome. In these ﬁbers Six proteins are essential to activate a
network of muscle genes, among which are the fast-type ones, while
expression of another subset of muscle genes is activated indepen-
dently in the same cells.Kinetics of fast and slow gene activation in the mouse embryo
To deﬁne the functions of Six genes in the activation of fast-type
myogenesis, we looked at the expression of several fast- and slow-
type muscle genes more precociously. In Fig. 5, both slow- and fast-
type mRNAs are detected at E9.5 in the primary myotome of the
mouse embryo (Figs. 5A–C and G–H). It seems, as previously reported
for the chick embryo (Sacks et al., 2003) that slow- and fast-type
genes are coordinately activated. In the SixdKO embryo, the
expression of fast-type muscle genes is not detected (Figs. 5A–C and
A′–C′) whereas muscle cells are present in the myotome as shown on
serial sections where Desmin expression can be detected (Figs. 5D–F
and D′–F′). Expression of slow-type muscle genes is not delayed and
can be detected in SixdKO embryos (Figs. 5G–H and G′–H′). Therefore,
Six genes are required to initiate, or to increase, the expression of fast-
Fig. 3. Expression of the MyHCs is still detected in SixdKO myotome. Immunohisto-
chemistry with Desmin, and MyHCs antibodies in control (A, B) and SixdKO (A′, B′)
E10.5 embryos (Nikon ×40). The dorsal aspect of the sections is up, the ventral aspect is
down. Quantiﬁcation of MyHCs/Desmin staining area in E10.5 control and SixdKO
embryos (C). Quantiﬁcation of at least 5 sections from two control and two SixdKO
embryos, error bars indicate standard deviation.
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could be indirect (through the activation of known direct targets of Six
in the somites, namely the transcription factors Pax3, MRF4 and/or
myogenin) or direct through the control of a network of fast-type
muscle genes by Six proteins.
Pax3 null embryos are not impaired in fast-type muscle gene activation
We have previously shown that activation of Pax3 expression in
the ventral dermomyotomal cells of the somite is under the control of
Six proteins. In the absence of Pax3 expression observed in SixdKO
embryos, muscle progenitors of this ventral lip are rerouted medially
and some of them die by apoptosis (Grifone et al., 2005). To
investigate if the loss of Pax3 expression and thus the loss of hypaxial
dermomyotomal progenitors could inﬂuence the differentiation of
primary myocytes, we looked at the expression of several fast-type
markers in E9.5 Pax3 null embryos. As previously described, the
myotome of Pax3 null embryos is severely shortened (Tajbakhsh et al.,
1997). We thus performed Desmin immunostaining on serial sectionsto reveal the size of the myotome remaining in Pax3 null embryo.
Expression of the fast-type genes is detected (Figs. 6A–B and A′–B′
and data not shown) in themyocytes of Pax3 null embryos (Figs. 6D–E
and D′–E′). Expression of slow-type genes in Pax3 null embryos was
also veriﬁed (Figs. 6C and C′, F and F′ and data not shown). These
results show that absence of Pax3 expression, absence of the
dermomyotomal ventral lip, and absence of hypaxial myotome do
not interfere with fast-type somitic myogenesis.
Mrf4 and Myogenin null embryos are not impaired in fast-type muscle
gene activation
Mrf4 is not detected and myogenin is strongly down-regulated in
E9.5 SixdKO (Grifone et al., 2005). Six proteins could drive the fast-
type muscle program by activating the transcription of Mrf4 and
Myogenin, which could thereafter act as the main activators of fast-
type muscle gene transcription. The second possibility is that
Myogenin and/or Mrf4 is speciﬁcally required with Six proteins to
activate the fast-type network of muscle genes characterized in this
study. Last possibility, neither Myogenin nor Mrf4 is speciﬁcally
required for this induction, which can take places with Six and any
MRF. MyoD is not yet activated in E9.5 mouse embryos; therefore, it
cannot be involved in somitic fast-type muscle gene activation. Early
expression ofMyf5 is not affected in SixdKO embryos, excluding a role
of Myf5 in activating fast-type muscle gene expression independently
of Six proteins. To analyse the role of Myogenin and Mrf4 in the fast-
type muscle phenotype, we studied the expression of several slow-
and fast-type muscle genes inMrf4 (Zhang et al., 1995) andMyogenin
(Hasty et al., 1993; Knapp et al., 2006) null embryos (Fig. 7). As
previously described the myotome of Mrf4 null embryos is severely
shortened due to the late onset ofMyf5 activation (Yoon et al., 1997).
We thus performed Desmin immunostaining on serial sections to
reveal the size of the myotome remaining in Mrf4 null embryos. In
contrast to Mrf4 null embryos, the formation of the myotome is not
affected in Myogenin null embryos (Venuti et al., 1995). Fast-type
muscle genes are still expressed in the remaining primarymyotome of
Mrf4 null embryos (Figs. 7A–B and A′–B′, D–E and D′–E′ and data not
shown) and inMyogenin null embryos (Figs. 7G–H and G′–H′ and data
not shown). Slow-type muscle genes are also correctly expressed in
Mrf4 (Figs. 7C and C′, F and F′ and data not shown) and Myogenin
(Figs. 7I and I′ and data not shown) null embryos. This excludes a
speciﬁc role for Mrf4 or Myogenin in controlling fast-type muscle
gene induction downstream of Six proteins.
Direct binding of Six proteins on the regulatory regions of identiﬁed
fast-type muscle genes
The analysis of the early expression of fast-type muscle genes in
the myotome of Pax3, Mrf4 and Myogenin KO suggests that Six
proteins directly controls the expression of a network of fast-type
muscle genes. To test the direct binding of Six proteins to the
regulatory elements present in those fast-type muscle genes
expressed early during mouse embryogenesis, we searched for
MEF3 sites in the -7500 to +2500 DNA region of genes down-
regulated in SixdKO (genes in Table 1). Potential MEF3 sites, matching
the MEF3 consensus sequence recognized by Six proteins, were
identiﬁed in the fast-type genes Atp2a1, Eno3, Myl1, Tnnc2, Tnnt3 and
in the slow-type Tnnc1 gene (Parmacek et al., 1994). MEF3 sites were
also identiﬁed in the regulatory regions of Iﬁtm3 (interferon induced
transmembrane protein), Kcne1l (potassium voltage-gated channel, Isk-
related family, member 1-like), Mybph (myosin binding protein H) and
Myeov2 (myeloma overexpressed 2) genes (Table 2 and Materials
and Methods). The function of Iﬁtm3, Kcne1l and Myeov2 is not yet
known and their regulation by Six proteins has not been reported in
other types of organogenesis known to be controlled by Six proteins
(Brodbeck and Englert, 2004; Zheng et al., 2003).
Fig. 4. Slow and fast-type structural proteins are co-expressed in the primary myotome of control E10.5 embryos. Co-immunohistochemistry on transverse sections of control
embryos at E10.5, using antibodies against Atp2a1 (A and A′) and Troponin I1 slow (B and B′). (A and B) Zeiss ×20. A′ and B′ are confocal images of themyotomal region delimited by
the white rectangles drawn in A and B, respectively (confocal Leica x63, zoom 3). (C) Merged of A′ and B′ showing colocalization of the fast and the slow proteins in all the myocytes.
Six1 and Six4 proteins are expressed in the progenitors of the dermomyotome and in the myocytes. Co-immunodetection of Six1 and Myogenin (D, confocal Leica ×63) showing
colocalization in the nuclei of the myocytes (yellow in D). Co-immunodetection of Six1 and Atp2a1 (E, confocal Leica ×63), Six4 and Atp2a1 (F, Zeiss 40) showing nuclear
accumulation of Six1 ad Six4 in all the myocytes expressing Atp2a1. DM, Dermomyotome, M, Myotome. For A–C, transverse sections; the dorsal aspect is up, the ventral aspect is
down. For D, E and F, sagittal sections; the rostral aspect is on the left, the caudal aspect is on the right and the dorsal aspect is down.
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cells, we show direct binding of endogenous Six1 and/or Six4 proteins
on the MEF3 sites of the fast-type genes Atp2a1 (-291), Atp2a1 (1205),Fig. 5. Six genes are required for the activation of the muscle fast-type program in the prima
using antibodies against desmin (D–F and D′–F′) on transverse sections of Six1−/+Six4−/+
and Atp2a1 are not detected in SixdKO embryos (A–C and A′–C′) whereas desmin positive cel
are correctly expressed in the remaining myotome of these mutants (G–H and G′–H′). The
desmin immunostaining have been performed on serial sections (A–C and D–F respectivelyMyl1 (-337) and Tnnc2 (-151). Six proteins are also boundon Iﬁtm3 (-59),
Kcne1l (-4964), Mybph (2357), Myeov2 (1633) and Tnnc1 (1119) MEF3
sites in differentiating C2C12 cells (Fig. 8). These results show the directry myotome. In situ hybridization (A–C, G–H, A′–C′, G′–H′) and immunohistochemistry
(A–H) and Six1−/−Six4−/− (A′–H′) E9.5 embryos. Fast-type muscle genes Tnnt3, Mylpf
ls are present in the myotome (D–F and D′–F′). Slow-type muscle genes Tnnt1 andMyl4
dorsal aspect of the sections is up, the ventral aspect is down. In situ hybridization and
, A′–C′ and D′–F′, respectively).
Fig. 6. Pax3 null embryos are not impaired in fast-type muscle gene activation. In situ hybridization (A–C and A′–C′) and immunohistochemistry using antibodies against Desmin
(D–F and D′–F′) on transverse sections of Pax3-/+ (A–F) and Pax3-/- (A′–F′) E9.5 embryos. Fast-type muscle genes Tnnt3 and Mylpf and slow-type muscle gene Tnnt1 are
expressed in Pax3-/- embryos. The dorsal aspect of the sections is up, the ventral aspect is down. In situ hybridization and Desmin immunostaining have been performed on serial
sections (A–C and D–F, respectively, A′–C′ and D′–F′, respectively).
Fig. 7. Mrf4 and Myogenin null embryos are not impaired in fast-type muscle gene activation. In situ hybridization (A–C and A′–C′) and immunohistochemistry using antibodies
against Desmin (D–F and D′–F′) on transverse sections ofMrf4-/+ (A–F) andMrf4-/- (A′–F′) E10.25 embryos. In situ hybridization and desmin immunostaining have been performed
on serial sections (A–C and D–F respectively, A′–C′ and D′–F′, respectively). In situ hybridization on transverse sections ofMyogenin-/+ (G–I) andMyogenin-/- (G′–I′) E9.5 embryos.
Fast-type genes Tnnt3 and Mylpf and slow-type gene Tnnt1 are expressed in Mrf4-/- and Myogenin-/- embryos. The dorsal aspect of the sections is up, the ventral aspect is down.
Arrows pinpoint the expression of Tnnt3, Mylpf, Tnnt1 and Desmin in Mrf4 null embryos.
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Table 2
MEF3 sites identiﬁed in the regulatory regions of genes down-regulated more than 3-
fold in E10.5 SixdKO embryos. Coordinates correspond to the mm8 (February 2006)
mouse genome assembly, obtained from the UCSC genome browser. Conserved
nucleotides compared to the MEF3 consensus sequence (5′GAAACCTGA or 5′
TCAGGTTTC) identiﬁed in Myogenin and Adolase A genes (Spitz et al., 1998) are in
bold letters. The relative location ofMEF3 sites in relation to the TSS (Transcription Start
Site) is indicated in base pairs, negative is upstream the TSS.
MEF3 sites in genes down-regulated more than three 3-fold in SixdKO embryos
Gene
symbol
chromosome start end MEF3 site location
vs. TSS
Fast-type genes
Atp2a1 chr7 126254512 126254539 GTAACTGGAGAA -291
chr7 126253016 126253027 GTAACCTGAGCT 1205
Eno3 chr11 70473035 70473046 GTAACCTGAGCC -956
Myl1 chr1 66877623 66877634 GAAATTGGATCC 617
chr1 66878577 66878588 GAAATTGAATCC -337
Tnnc2 chr2 164471090 164471125 GAAATTTAAGCT -151
Tnnt3 chr7 142308186 142308197 GACATCTGATCT -47
Other genes
Tnnc1 chr14 30038440 30038451 GTAACCTGACCA 1119
Iﬁtm3 chr7 140862123 140862134 GTAATTTGATCC -59
Kcne1l chrX 137557530 137557541 GATAACGGATAC -4964
Mybph chr1 136011713 136011724 GAAACTTGATCC 1854
chr1 136007502 136007513 GAAATCTGAACC 2357
Myeov2 chr1 94470720 94470731 GAAACTTGAACC 1633
MEF3 consensus binding site
(myogenin and aldolase A)
GAAACCTGA
Fig. 8. Six proteins are bound on the MEF3 sites of muscle genes. ChIP assays from
differentiating C2C12. Assays were performedwith Six1 and Six4 antibodies or IgG from
preimmune rabbit serum. Aliquots of 0.1% and 0.2% input chromatin (before ChIP) was
also ampliﬁed by the same primer pairs to ensure PCR efﬁciency and linearity.
Immunoprecipitated chromatin was ampliﬁed by semi-quantitative PCR. Exon8 of
Chrna1 gene was used as a negative control. The location of MEF3 sites in relation to the
TSS is indicated in base pairs, negative is upstream the TSS.
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in myogenic cells, and therefore the ability for Six proteins to modulate
their expression.
Forced Six1 or Six4 expression can activate fast-type muscle gene
expression in SixdKO myoblasts
To determine the ability of Six homeoproteins to modulate the
transcription of identiﬁed myotomal expressed muscle genes, we
established primary myogenic cells devoid of endogenous Six1 and
Six4 activity. For that purpose, primary myogenic cells from E18
SixdKO fetuses were cultured. These cells were transfected with
expression vectors encoding the control Green Fluorescent Protein
(GFP), Six4, or Six1 proteins. Forty-eight hours after transfection,
mRNA from transfected cells was isolated and RT-PCR experiments
were performed.We established that forced expression of Six1 and/or
of Six4 is able to activate expression of the genes identiﬁed in the
Affymetrix experiments (Fig. 9). The expression of Myogenin, known
to be regulated by Six proteins, is activated by Six1. The expression of
several fast-type muscle genes, including Atp2a1, Myl1 and Tnnt3, is
up-regulated by both Six1 and Six4 (compared to Atp2a1, Myl1 and
Tnnt3 expression in cells transfected with GFP). We noticed that the
expression of Srl and Eno3 is only up-regulated by Six1 in these cells.
In contrast to fast-type muscle genes, the expression of slow-type
muscle genes is not modiﬁed by forced Six4 or Six1 expression (see
Atp2a2, Tnni1 and Tnnt1 expression). Expression of some other genes
identiﬁed in our Affymetrix analysis is also activated by Six proteins:
Iﬁtm3 and Kcne1l by Six4. These transfection experiments show that
Six1 and Six4 can induce the expression of most of the genes down-
regulated in themouse SixdKO embryo in primarymyogenic cells. This
is not the case in primary embryonic ﬁbroblastic cells where forced
expression of Six1 was unable to activate myogenic Six targets
(myogenin, Atp2a1,Myl1 and Tnnt3; N.S and P.M, unpublished results).
Discussion
To unravel the network of genes under the control of Six
homeoproteins during early myogenesis we compared the transcrip-
tome of E10.5 control and SixdKO embryos. We have previouslyshown that during this embryonic period Six proteins have genetically
important roles in controlling the expression of Pax3 as well as genes
of the Muscle Regulatory Factor (MRF) family known to have a master
regulatory function in myogenesis. Here, using Affymetrix wide
transcriptomal analysis, we reveal that Six homeoproteins are also
essential to activate several muscle structural genes expressed in
differentiating myocytes present in the embryonic primary myotome.
Among these structural genes, Six proteins are more speciﬁcally
involved in activating fast-typemuscle genes, whose expression in the
adult muscle is restricted to so-called fast-type ﬁbers. In contrast to
the adult situation, there is nomyocytes expressing only fast- or slow-
Fig. 9. Six1 and Six4 expression can activate fast-type muscle genes expression in
SixdKO myoblasts. RT-PCR experiments were performed with mRNA isolated from
primary myogenic cells of E18.5 SixdKO fetuses transfected with expression vectors
encoding GFP, Six4 or Six1 proteins.
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slow-type muscle genes are co-expressed in the myocytes present in
the primary myotome. Here we present evidence that the expression
of fast-type genes in these embryonic mixed slow/fast-type ﬁbers is
under the control of Six homeoproteins that accumulate in their
nuclei.
Models of slow- and fast type muscle differentiation
We show here that the expression of several genes expressed early
in the mouse somites (fast-type muscle genes Atp2a1, Tnnt3 and
slow-type muscle genes MyHCs, Tnni1) are co-expressed in the
myocytes present in the early mouse myotome, while in the adult
these genes are speciﬁcally expressed in either fast-type or slow-type
muscle ﬁbers. How is the muscle mixed slow/fast phenotype
controlled in the mouse myotome, and how is this phenotype
maturing during embryogenesis to give rise to slow- and several
subtypes of fast-type muscle ﬁbers remains to be established. Indeed,
our present analysis, which completes existing analysis (Lyons et al.,
1990; Sacks et al., 2003), supports the existence of a primary
myotome expressing both slow- and fast-type muscle genes. In
rodents, based on the expression of slow- and embryonic fast-type
MyHC, it has been shown that until E16 primarymyoﬁbers co-express
these twomuscle genes in all primary myoﬁbers (Condon et al., 1990;
Gunning and Hardeman, 1991; Hallauer and Hastings, 2002; Kelly andRubinstein, 1980; Lyons et al., 1990; Narusawa et al., 1987). So, after a
precocious coordinate activation of embryonic, slow- and fast-type
muscle genes immediately after myogenic differentiation in the
embryo, a later restriction of ﬁber-type isotype patterns takes place
resulting in the selective turnoff of expression of inappropriate
isotypes later in development (Hastings and Emerson, 1982). Until
E16, myoﬁbers have a mixed slow/fast phenotype and express a
speciﬁc combination of transcription factors allowing the activation of
both slow- and fast-type muscle genes in a non-exclusive manner.
Whether slow/fast heterogeneity exists before E16, in either
myogenic progenitors or in nascent myoﬁbers, remains to be
determined with the analysis of the expression pattern of new
genetic markers which may allow to identify more precocious
heterogeneity in embryonic myoﬁbers or embryonic myogenic
progenitors. This heterogeneity should exist and permit speciﬁc
slow- and fast-type neuromuscular junction formation between E13
and E15 (Rafuse et al., 1996). Accordingly, the early myotome is not
innervated. How fast- and slow-type myogenic features are estab-
lished for the ﬁrst time during embryogenesis is not completely
resolved. A few transcription factors have been shown to be enriched
in the nuclei of adult slow- or fast-type muscle ﬁbers and responsible
for their speciﬁc slow or fast phenotype (review in Zierath and
Hawley, 2004). On the basis of existing data, the genesis of muscle
ﬁber-type heterogeneity during development in amniotes does not
appear to depend on those transcription factors characterized in the
adult and which are mainly targets of calcium signaling induced by
motorneuron ﬁring (Issa et al., 2006; Oh et al., 2005). In the zebraﬁsh
embryo (reviewed recently by Ochi and Westerﬁeld, 2007), adaxial
cells are committed to the slow lineage under the inﬂuence of the Hh/
Prdm1 pathway (Baxendale et al., 2004; Hirsinger et al., 2004; Roy et
al., 2001), while the fast-type lineage is activated by the retinoic acid/
FGF8 pathway (Groves et al., 2005; Hamade et al., 2006). Sox6, a
known inhibitor of slow-type muscle genes is under the negative
control of Prdm1, in adaxial cells (von Hofsten et al., 2008). Thus,
contrary to the situation in amniotes, early during zebraﬁsh
embryogenesis slow- and fast-type muscle genes are activated in
separate lineages (Chauvigne et al., 2005; Hirsinger et al., 2004; Ochi
andWesterﬁeld, 2007), although primary slow adaxial myogenic cells
initially coexpress slow- and fast-type myosin heavy chains (Bryson-
Richardson et al., 2005). Sox6 protein is known to negatively control
the expression of slow-type muscle genes, and Sox6 null mice present
a muscle phenotype, but only after E15 during fetal development. This
phenotype ﬁts well with the absence of a major function of this gene
before E15, while it appears crucial at the time when myoﬁbers take
the decision to become either slow or fast (Hagiwara et al., 2007).
Six1 and Six4 control the establishment of fast-type features in
embryonic muscles
We have shown that Six proteins are transcription factors
controlling the adult fast/glycolytic muscle phenotype (Grifone et
al., 2004). By analysis of the transcriptome of SixdKO somites, we
show here that Six1 and Six4 are involved in the control of a network
of fast-type muscle genes early during development. The expression
of genes speciﬁc of the adult fast phenotype (Tnnt3, Atp2a1, Mylpf)
and which is initiated around E9.5 in wild-type mouse embryos, is
severely impaired in the absence of both Six1 and Six4 in the early
myotome. Contrary, the expression of genes speciﬁc of the adult slow
phenotype (Tnnt1, Myl4), which is also initiated around E9.5 in wild-
type mouse embryos, is preserved in the remaining myotome of
SixdKO embryos. Furthermore, we show that the expression of Prdm1,
a transcriptional repressor of fast-type muscle genes in zebraﬁsh
known to relay Hedgehog signaling, is preserved in the myotome of
SixdKO embryos. It will be interesting to test whether Prdm1
proteins accumulate in the nuclei of mixed slow/fast somitic
myocytes in amniotes, since this transcription factor is known to
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prevent their activation in zebraﬁsh embryos (Von Hofsten, 2008;
Liew, 2008). In somitic myocytes, and until embryonic myoﬁbers
adopt either a slow or a fast phenotype, Sox6 and Prdm1 inhibitory
transcription factors should not be active, to allow both slow- and fast-
type muscle gene expression in every myocyte. In those myocytes, Six
proteins integrate environmental cues that allow the formation of an
active STC able to activate a network of muscle genes in synergy with
MRF. Contrary to what is observed in the mouse somites, in the
zebraﬁsh embryos, Six1 gene expression is only detected in the fast-
type myotome and not in adaxial cells and its knock down expression
abolishes the induction of fast-typemuscle gene expression (Bessarab
et al., 2008). This data argues for a conserved evolutionary function of
Six homeoproteins at the onset of the fast-type muscle program
activation in vertebrates.
Other networks of muscle genes are activated in the somitic
myocytes by the synergy of MRF and other transcription factors. MEF2
(de Angelis et al., 2005) and FoxO1 (Kitamura et al., 2007) are good
candidates present in the early myotomes to activate slow-type
muscle genes, as well as muscle genes expressed in both slow- and
fast-type ﬁbers like desmin and titin. We show that myotomal Vito1
expression (Mielcarek et al., 2002), a cofactor of TEF and MEF2
proteins (Maeda et al., 2002), is preserved in SixdKO embryos. Vito1
mRNAs accumulate preferentially in adult slow muscle ﬁbers (A.
Guernec, P.M, unpublished observation) and MEF2 proteins are
mainly involved in the activation of slow-type muscle genes in the
adult (Potthoff et al., 2007). Therefore, it is tempting to speculate that
remaining TEF-Vito and MEF2-Vito transcriptional complexes still
present in SixdKO embryos activates, in synergy with Myf5, the
expression of slow-type muscle genes in the myotome.Six act in differentiated myogenic cells of the myotome in a cell
autonomous fashion to initiate fast-type muscle gene expression
Early myogenesis in the mouse embryo is ﬁrst detected at the
somitic level by the expression ofMyf5 around E8 in the dorsal aspect
of the dermomyotome of rostral somites (Ott et al., 1991). Early
expression of Myf5 is under the control of Wnt and Hh signaling,
acting on its epaxial enhancer (Borello et al., 2006; Borycki et al.,
1999; Ikeya and Takada, 1998; McDermott et al., 2005; Munsterberg
et al., 1995). Later in development, myogenic progenitors arise from
the hypaxial, the anterior and the posterior lips of the dermomyotome
(Denetclaw et al., 1997; Gros et al., 2004; Kahane et al., 2002; Venters
et al., 1999). In SixdKO embryos, we have shown that Pax3, a marker
of the myogenic progenitors present in the dermomyotomal lips, is
not expressed in the hypaxial and epaxial aspects of the dermomyo-
tome. Its expression, however, is higher in the anterior and posterior
dermomyotomal lips when compared with control embryos. Six1 and
Six4 are thus only required in dorsal and ventral morphogenetic
centers of the somites to activate Pax3. By controlling the expression
of Pax3 in the ventral dermomyotomal lip, Six homeoproteins and
their Eya cofactors control hypaxial myogenesis, i.e., ventral myogen-
esis at the thoracic and abdominal level, as well as at the limb level
(Grifone et al., 2007). Analysis of embryos devoid of Pax3 activity
provides evidence (i) that hypaxial lip formation is not required for
the induction of myotomal fast-type and slow-type muscle genes,
demonstrating that no major signaling molecules come from this
dermomyotomal structure or from hypaxial myocytes to drive the
differentiation of myotomal cells; (ii) and that Pax3 is not directly
involved in fast-type muscle gene activation, contrary to its known
role in muscle gene activation in the myotome (Lagha et al., 2008), or
in the myogenic progenitors in the limbs (Bajard et al., 2006). These
data and the transfection experiments with Six1 or Six4 in SixdKO
myogenic cells argue that Six acts in differentiated myogenic cells in a
cell autonomous fashion to initiate fast-type muscle gene expression.Six genes directly regulate muscle fast-type gene expression
In SixdKO embryos, a reduced primary myotome is formed.
Myocytes of this mutant myotome come from myogenic progenitors
of the early epaxial, and of the anterior and posterior lips of the
dermomyotome. By Desmin expression analysis, we show here that
the primary myotome of SixdKO embryos is smaller than that of the
control myotome. In control embryos, Six genes are not only
expressed in the myogenic progenitors but also in the myotome
itself, regardless of the anterior/posterior/dorsal/ventral origin of the
myocytes. Here, we illustrate the nuclear accumulation of Six1 and
Six4 in the cells of the myotome and the dermomyotome, arguing for
a role of these homeoproteins in the control of genes in the myogenic
progenitors and also in the post mitotic myocytes (present study).
Therefore, although Pax3, and then Myf5, can be activated in the
anterior and posterior dermomyotomal cells of the somites indepen-
dently of Six1/4 homeoproteins, post mitotic myocytes normally
express Six1 and Six4 genes at the onset of Myf5 activation. Six
proteins are normally recruited on the promoter region of Myogenin
and are required in collaboration with Myf5, Pbx, NF1 and MEF2
proteins, for its activation (Berkes et al., 2004; Spitz et al., 1998).
Activation of Myogenin in the myotome of E9.5 SixdKO embryos is
severely impaired (Grifone et al., 2005). The activation of muscle
speciﬁc genes is initiated by the binding of the determination factors
Myf5, Myod or Mrf4 to the regulatory regions of downstream target
genes (structural muscle genes, Myogenin) to facilitate chromatin
opening and the activation of these targets (Bergstrom et al., 2002;
Gerber et al., 1997). Myogenin acts later on the E boxes occupied by
themyogenic determination factors (Cao et al., 2006; de la Serna et al.,
2005). In E9.5 Myf5lacz KO embryos (which do not express Mrf4), no
myogenesis occurs, and Six1/4/Pax3 positive cells of the dermomyo-
tome adopt non-muscle fates (Tajbakhsh et al., 1997). Six1/4 and
Pax3 are thus not sufﬁcient by their own to activate structural muscle
genes like theMyHC or Tnnt in the absence of MRF. Accordingly Six1/
4 and Pax3 homeoproteins are expressed in other tissues during
embryogenesis (like the dorsal root ganglia) where they do not
activate structural muscle genes. Therefore, Six proteins must
cooperate with one MRF to activate downstream structural muscle
gene expression in the mouse embryo. In the early E9–E10 mouse
embryo, only Myf5, Mrf4 and Myogenin are expressed. Myod
expression is initiated later. In the experiments presented here at
E9.5, Myf5 is the only MRF whose expression is robust in mutant
embryos, Mrf4 and Myogenin being strongly down-regulated in the
SixdKO embryos (Grifone et al., 2005). As Mrf4 and Myogenin are
two downstream targets of Six proteins in the mouse somites, they
could partially or totally be responsible for the speciﬁc down-
regulation of the expression of speciﬁc categories of muscle genes
observed in SixdKO. To test the involvement of individual MRFs
expressed in E9.5 myocytes (namely Myogenin and Mrf4) in the
activation of myotomal fast-type muscle genes, we analyzed the
expression of slow- and fast-type muscle genes in several mutant
backgrounds. We provide evidence by analyzing Mrf4 (Zhang et al.,
1995) and Myogenin (Hasty et al., 1993) mutant embryos, in which
fast-type markers are still expressed, that Mrf4 and Myogenin have a
minor role in the SixdKO phenotype observed. Our data supports a
model in which Six proteins are necessary to activate a network of
muscle structural genes, in association with Myf5 and ubiquitous
proteins, which may include Pbx proteins (Maves et al., 2007). The
fast-type muscle genes identiﬁed in this study belong to thisMyf5-Six
network. According to these results, muscle genes identiﬁed in this
study posses MEF3 binding sites in their regulatory regions, that are
bound by Six proteins in myogenic cells, and E boxes that are bound
my MRF. Most of the genes identiﬁed in this study are already known
to be controlled byMyod and/orMyogenin transcription factors (Blais
et al., 2005; Davie et al., 2007; de la Serna et al., 2005). More precisely,
most of the genes down-regulated in the SixdKO appear to be
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2005). This is the case for Myogenin, Tnnc2, Tnnt3, Myh3, Mylpf,
MybpH, Eno3 and Atp2a1. It is interesting to speculate that Myf5 and
MyoD share the ability to recruit the Brg1 complex and to hypothesize
a synergy between Myf5-Brg1 and Six homeoproteins that would
trigger the expression of the aforementionedmuscle genes in the early
myocytes. It is therefore likely that the Myf5-Brg1 complex makes the
myogenic MEF3 targets accessible for activation by the Six transcrip-
tional complexes and that both transcription complexes co-regulate a
large battery of direct muscle targets in the mouse myotome.
Putative mechanisms underlying the coexistence of slow and fast
properties in amiote embryonic muscles related to Six transcriptional
activity
Binding of Six proteins to the identiﬁed MEF3 elements should
allow the STC to modulate the level of transcription of corresponding
genes. Slow-type and fast-type muscle genes are coexpressed in the
same mixed slow/fast myocytes in the wild-type myotome. In adult
myoﬁbers slow- and fast-type muscle genes are preferentially
expressed in a group of muscle ﬁbers, according to the speciﬁc activity
of different slow-type (FoxO1, MEF2, PPARδ/PGC1α, NFATc1) and
fast-type (Six, MyoD, MusTRD) transcription factors (Issa et al., 2006;
Kitamura et al., 2007; Schuler et al., 2006; Tothova et al., 2006; Zierath
and Hawley, 2004). It is assumed that the transcription factors that
control the expression of fast- and slow-type muscle genes in somitic
myocytes are active in the same cells, driving a mixed slow/fast
phenotype. Slow Tnnc1 is the ﬁrst gene for which aMEF3 site has been
identiﬁed in its skeletal enhancer (Parmacek et al., 1994). This MEF3
site is required for its enhancer activity in C2C12 myogenic cell lines,
where both slow- and fast-type muscle genes are activated. To our
knowledge, the activity of this enhancer has not been studied in adult
fast- and slow-type muscles. Tnnc1 expression is not detected in the
myotome of E10.5 SixdKO embryos (data not shown) and the MEF3
site present in the Tnnc1 skeletal enhancer is bound by Six proteins in
ChIP experiments performedwith C2C12differentiating cells.Wehave
previously shown that the muscle promoter of the aldolase A gene is
boundby Six proteins in the slow/oxidativeﬁbers of the soleusmuscle.
Nevertheless, the complex formed on the aldolase AMEF3 site is not as
active in slow/oxidative myoﬁbers, as compared with its transcrip-
tional strength in fast/glycolytic ﬁbers (Grifone et al., 2004; Salminen
et al., 1996; Spitz et al., 1997). This showed that the STC activity can be
either high or low, depending on the cell, probably reﬂecting its
differential composition (Grifone et al., 2004). High STC activity has
been shown to be sufﬁcient to exclude the slow/oxidative program in
adult muscle ﬁbers (Grifone et al., 2004), suggesting that during
embryogenesis a low STC activity would be present in mixed
myocytes/myoﬁbers, compatible with the expression of slow-type
muscle genes, probably until E16, whenmixedmyoﬁbers adopt a slow
or a fast phenotype. This low STC activity would explain the lack of the
polyMEF3 reporter activity in the early myotome of corresponding
transgenic animals (Grifone et al., 2007). Nonetheless, we show here
that Six1 and Six4 accumulate in the nuclei of the myocytes and
activate different classes of enhancers harboring MEF3 sites, in
cooperation with transcription factors present in these cells, namely
MRF. Six can thus activate, at least transiently during embryogenesis,
the expression of a variety of muscle genes harboring MEF3 sites in
their regulatory regions, even if these genes are no more expressed at
high levels in adult fast-type myoﬁbers. This is the case for Myogenin
(Hughes et al., 1999) and Tnnc1. Accordingly, no down-regulation of
Myogenin and Tnnc1 expression was observed in fetal muscles of
E18.5 SixdKO (A. Richard, P.M., unpublished data).
We show here that Six1 and Six4 are initially expressed in all mixed
slow/fast myocytes. So why do not all thesemyocytes differentiate into
a fast phenotype? As written above, Six proteins are enriched in adult
fast-type nuclei, where they form transcription complexes able toactivate target genes more efﬁciently than the transcription complexes
they form in slow-type nuclei (Grifone et al., 2004; Salminen et al.,
1996). In agreement with this data, the polyMEF3-lacz transgene (a
repetition of MEF3 sites upstream of a minimal promoter which is
constituted by a TATA box) is only active in fast-type IIB ﬁbers in adult
mice (Grifone et al., 2004). In E9-E13 embryos, this transgene is not
active in the differentiated myoﬁbers (Grifone et al., 2007), suggesting
that the activity of the STC is up-regulated in post mitotic myoﬁbers
between E13 and adult. It is known that during mouse development,
between E16 and birth, MyHCs and fast-type MyHCemb expression
becomes restricted to slow- or fast-type ﬁbers, respectively (Condon et
al., 1990; Gunning and Hardeman, 1991; Hallauer and Hastings, 2002;
Kelly and Rubinstein, 1980). During this fetal period, STC activity could
become higher in the nuclei of future fast-type ﬁbers, according to yet
unidentiﬁed environmental cues. In these myoﬁbers, high STC activity
could act as master fast-type transcription factors, excluding the slow
phenotype, as observed after Six1-Vp16 or Six1/Eya1 forced expression
in adult soleus myoﬁbers (Grifone et al., 2004). This increase in activity
of the STC should be necessary to maintain the expression of a network
of fast-type muscle genes and to increase Sox6 activity, required to
inhibit the slowmuscle program in those ﬁbers (Hagiwara et al., 2007).
New genes identiﬁed by our study
Our study reveals the down-regulation of genes encoding signaling
molecules such as Iﬁtm3, a transmembrane protein with guidance and
cell adhesion properties (Lange et al., 2008; Tanaka et al., 2005),
Myeloma overexpressed geneMyeov-2 which has been characterized
in gastric carcinoma (Janssen et al., 2000), Kcne1l a beta subunit of the
voltage-gated potassium channel I(Ks) (Piccini et al., 1999), or
Interleukin 17b gene Il17b (Moseley et al., 2003). It will be interesting
to characterize in detail the expression pattern of these genes in the
mouse embryo and in adult muscle ﬁbers to know whether Six
controls their expression in post mitotic myoﬁbers or/and in
myogenic progenitors. Considering the other targets of Six identiﬁed
in this study, our results show that Six homeoproteins control a
battery of muscle genes involved in several processes: transcription
factors (Mrf4, Myogenin), sarcomeric proteins (Myosins, Troponins),
intracytoplasmic K+ and Ca2+ concentration control (Kcne1l, Atp2a1,
Sarcalumenin), signaling pathways (Il17b), cell adhesion proteins
(Iﬁtm3) and metabolism (Enolase 3).
In conclusion, ourwork describes the unanticipated involvement of
a family of homeoproteins, the Six proteins, in the earliest steps of
muscle differentiation in the mouse embryo. We show that Six factors
are essential for the activation of fast-type muscle genes in mixed
slow/fastmyocytes, in addition to their known functions in controlling
the adult muscle ﬁber fast/glycolytic phenotype, providing evidence
that these homeoproteins control muscle ﬁber-type diversity from its
onset to the adult stage (Fig. 10). This study also characterizes the early
targets of Six homeoproteins in the ﬁrst post-mitoticmyogenic cells in
the embryo. Comparison of these early targets with the targets of Six
during late embryonic and fetal myogenesis will be an important goal
to characterize in more details the network of muscle genes under the
STC at several developmental stages and how mixed slow-fast ﬁbers
become progressively restricted in their slow or fast phenotype
according to Six and Six cofactor gene expression.
Materials and methods
Genotyping
SixdKO embryos are identiﬁed by the fusion of the ﬁrst and second
branchial arches (Grifone et al., 2005). Six1−/+Six4−/+ and wild-type
embryos were genotyped by PCR ampliﬁcation of the mutated Six4
allele (Giordani et al., 2007). Six1−/+Six4−/+ were used as control.
Pax3, Mrf4 and Myogenin embryos are genotyped by PCR using the
Fig. 10. Six1 and Six4 control several important steps of muscle development through the control of master genes speciﬁc of each of these steps. We have shown that Six1 binds the
hypaxial Pax3 enhancer (Grifone et al., 2007) and that hypaxial Pax3 expression is abolished in the dermomyotome of SixdKO, precluding genesis of hypaxial myogenic progenitors
(Grifone et al., 2005). Six proteins are also involved in the activation ofMrf4 in the mouse somite (Grifone et al., 2005), ofMyoD (Grifone et al., 2005) and ofMyogenin (Spitz et al.,
1998). We have shown already that accumulation of Six1 and its Eya1 cofactor is more robust in the nuclei of adult fast-type myoﬁber in which this Six1-Eya1 transcriptional
complex drives the activation of fast-type muscle genes (Grifone et al., 2004; Himeda et al., 2004). We show here that Six1 and Six4 are required for the activation of the fast-type
muscle program in the somitic slow/fast myocytes present in the primary myotome of mouse embryos. This activation is achieved through the direct binding of Six1 and Six4 to the
regulatory sequences of muscle target genes. The expression of slow-type muscle genes is maintained in SixdKO somitic myocytes.
179C. Niro et al. / Developmental Biology 338 (2010) 168–182following primers: Pax3mutantF, 5′-CCT CTA CAG ATG TGA TAT GGC
TGA; Pax3mutantR, 5′-TTT TTT GGG GGA GGA GCT CTC CGA GAT CCG;
Pax3wildtypeF, 5′-AGC ACC TTT AAG CAA ACC GAA AGG CAT TGC;
Pax3wildtypeR, 5′-TTT TTT GGG GGA GGA GCT CTC CGA GAT CCG;
Mrf4mutantF, 5′-GAT TGG GAA GAC AAT AGC AGG C; Mrf4mutantR,
5′-TTC TCT TGC AAG TCT TGC AAG CCC, Mrf4wildtypeF, 5′-GGG AGA
CTG ATG CTC CAT GAC AGC; Mrf4wildtypeR, 5′-TTC TCT TGC AAG TCT
TGC AAG CCC; MyogwildtypeF, 5′-GGA GTG GTC CTG ATG TGG T;
MyogwildtypeR, 5′-CGA CAA GGA AAG GGG TCC A; MyogmutantF, 5′-
GGA GTG GTC CTG ATG TGG T; MyogmutantR, 5′-TGG ATT ACA TGT
GAT TCC CCT.
RNA extraction and Affymetrix microarrays
E10.5 embryoswere eviscerated, headand limbswere discarded, the
neural tube was removed, and RNA was prepared from the remaining
axial tissues with the RNeasy Fibrous Tissue kit (QIAGEN). Total RNA
wasprepared fromﬁve samples: threemutant samples (each composed
of one SixdKO embryo) and two control samples (one composed of two
wild-type embryos and the other one composed of two Six1−/+Six4−/+
embryos). Quality control of RNAwas performed with the Agilent 2100
bioanalyzer. cDNA synthesis was performed with 3μg of total RNA.
Resulting cDNAwas ampliﬁedoncewith the T7RNApolymerase (1500-
fold ampliﬁcation). For each sample, 10 μg of biotinylated cRNA was
hybridized on Affymetrix mouse genome 430A2.0 array (Affymetrix,
Strasbourg, France). The hybridization results were extracted using
GeneSpring software and normalized using MAS5. The set of probes
differentially expressed between control and SixdKO embryos was
determined on the basis of a t-test. All geneswith a fold change N3 and a
p value of b0.05 were considered to show signiﬁcant differential
expression between SixdKO and control embryos. Affymetrix data are
available on ArrayExpress (experiment name: E10.5 SixdKO, accession:
E-MEXP-1849).
Whole mount and section in situ hybridization
Whole mount in situ hybridization experiments were performed
as previously described (Grifone et al., 2007). Cryostat sections(12 μm) were treated with 1 μg/ml proteinase K in TE (Tris–HCl
100mM, EDTA 5mM) for 7min at 37 °C. Slides werewashed in 1× PBS
and ﬁxed for 15 min at RT in 4% PFA. After two washes in 1× PBS,
slides were treated with 0.25% acetic acid containing 0.15 M
triethanolamine. Slides were then washed twice in 1× PBS and
prehybridized for at least 2 h at 68 °C in hybridization buffer
containing a salt solution (3 M NaCl, 10 mM Tris, 50 mM NaH2PO4,
50 mMNa2HPO4, 50 mM EDTA), 50% formamide, 10% dextran sulfate,
1 mg/ml yeast tRNA and 1× Denhardt's solution. Hybridization buffer
was replaced by fresh buffer containing 1 mg/ml digoxygenin (DIG)-
labeled antisense RNA probe for hybridization overnight at 68 °C.
Slides were rinsed in 5× SSC and washed twice in 0.2× SSC for 30 min
at 68 °C. After two washes in PTW (1× PBS+0.1% Tween-20) at room
temperature, slides were incubated for 1 hour in PTW supplemented
with 10% goat serum and two hours in PTW containing 10% goat
serum and 1/2000 alkaline phosphatase labeled anti-DIG Fab
fragments (Roche). Signals were detected with NBT/BCIP substrate
(Vector laboratories). For each probe, experiments have been
performed at least once by whole mount in situ hybridization at
E10.5 and on at least six sections from two to three embryos by
section in situ hybridization at the forelimb/thoracic level.
DIG-labeled antisense RNA probes for Vito1 and Prdm1 were
prepared from linearized plasmids. DIG-labeled antisense RNA probes
for Atp2a1, Myl1, Myl4, Myl6b, Mylpf, Srl, Tnnc2, Tnni1, Tnnt1, Tnnt3
were prepared from PCR productswith reverse primers containing the
T7 polymerase sequence (5′-TAATACGACTCACTATAGGGC+reverse
sequence). Primers used for PCR from E10.5 embryos cDNA: Atp2a1F,
5′-GACCTGCTTGTGCGGATTCTT; Atp2a1R, 5′-CAA TGGCGT TGGCAA
TGAGG;Myl1F, 5′-ATC GAG TTC TCT AAGGAG CAA CA;Myl1R, 5′-GCA
GACCCTCAACGAAATCTT;Myl4F, 5′-AAGAAACCCGAGCCTAAGAAG
G; Myl4R, 5′-TGG GTC AAA GGC AGA GTC CT; Myl6bF, 5′-GTT CTT TGG
CCA CCT GAC AT; Myl6bR, 5′-CTC GAT CAC CAC TTT GGA GAG; MylpfF,
5′-CTG GAC CCA GAA GGG AAG G; MylpfR, 5′-TGC CCA CAT GTT CTT
GAT CT; SrlF, 5′-CCC CTG GAG CAG TCT TAC AA; SrlR, 5′-ATG CCC TCA
ATG GTT TTC AG; Tnnc2F, 5′-TGA TGA AGG ATG GTG ATA AAA ACA A;
Tnnc2R, 5′-GCA GTC TGG ATG GAC ACG AAC; Tnni1F, 5′-ATG CCG GAA
GTTGAGAGGAAA; Tnni1R, 5′-TCCGAGAGG TAACGCACC TT; Tnnt1F,
5′-CCC CCG AAG ATT CCA GAA GG; Tnnt1R, 5′-TGC GGT CTT TTA GTG
180 C. Niro et al. / Developmental Biology 338 (2010) 168–182CAA TGA G; Tnnt3F, 5′-GGA ACG CCA GAA CAG ATT GG; Tnnt3R, 5′-
TGG AGG ACA GAG CCT TTT TCT T.
Chromatin immunoprecipitation (ChIP)
We searched for MEF3 sites in the promoter region of the down-
regulated genes. Ten kilobases of sequence (from 7.5 kb upstream to
2.5 kb downstream relative to the transcriptional start sites) were
surveyed using the CisGenome program (Ji et al., 2008).
The MEF3 site matrix that was used for this search was generated
de novo using a Gibbs sampling strategy (Liu et al., 1995)
implemented in CisGenome. The sequence data input comprised
376 genomic binding sites of Six1 in proliferating C2C12 myoblasts, as
identiﬁed by ChIP-on-ChIP. A detailed analysis of this data will be
published in full elsewhere (Yubing Liu and Alexandre Blais).
Chromatin immunoprecipitation was performed from C2C12 cells
after 1 day in differentiation medium as previously described (Blais et
al., 2005). The Six1 and Six4 antibodies were generated in rabbits as
described in Spitz et al. (1998) and puriﬁed by afﬁnity to the cognate
recombinant proteins (A.B. unpublished reagent).
Chrna1 (cholinergic receptor, nicotinic α polypeptide1) exon8
devoid of MEF3 site was ampliﬁed as a ChIP negative control. Primers
used were as follows: Atp2a1 (-291) F 5′-CCC AGT TGC CTC AAC TTC
TC, Atp2a1 (-291) R 5′-CTG TGACAGTGGAAAGGGGT; Atp2a1 (1205)
F 5′-AGAGTAGGGGACCAA CCAGG, Atp2a1 (1205) R 5′-CAAGGGCTT
CAA GAG CTC AG; Myl1 (-337) F 5′-CAG TCA TGG TTG GTT TGG TG,
Myl1 (-337) R 5′-CCT CAG CCA AAA TTC CAA GT; Tnnc2 (-151) F 5′-
GTA GGG GCA TCC TCT CTT CC, Tnnc2 (-151) R 5′-AAA TTT CCC TGC
AAA GGA CC ; Iﬁtm3 (-59) F 5′-TCA AAT TAC TCC AGG GCA GG, Iﬁtm3
(-59) R 5′-ACTCCAGGACCCCTCACTCT ; Kcne1l (-4964) F 5′-ACC TTG
AGGGTT TGGCCTAC, Kcne1l (-4964) R 5′-TTGAGATGTGAGCAAGGT
GC ;MybpH (2357) F 5′-TTT GCAGGG TGCATTAAC CT,MybpH (2357)
R 5′-GCC CGT GTC TCT CTT CAC TC; Myeov2 (1633) F 5′-TTG TGC CAG
TTA GTC ACC CA, Myeov2 (1633) R 5′-CTC CAG GGA AAC TTG AAC CA;
Tnnc1 (119) F 5′-GCA TAC CAA AGT CCC CAG AA; Tnnc1 (119) R 5′-
AGC TGTCCC TCAGGTTGAGA; Chrna1 F 5′-GACAAGCCTCTGACTCAT
GAT CTA TGT; Chrna1 R 5′-GCT GCC GGT CCT ACT CCA CCC TGG CT.
Mouse primary myogenic cells transfections
Mouse primary myogenic cells were isolated from back residual
muscles of E18.5 Six1−/−Six4−/− fetuses. Muscles were rinsed and
minced in 1× PBS and then disrupted by incubation at 37 °C with
0.05% proteinase (Sigma). Myoblasts were mechanically separated
from muscle ﬁbers by pipetting and ﬁltered through a 40 μm nylon
ﬁlter. After several centrifugations to pellet cellular debris, cells were
plated on 150 cm2 culture ﬂasks for 1 h to remove ﬁbroblasts. Non-
attached cells were recovered and plated on growth factor-reduced
Matrigel (BD, Biosciences)-coated 25 cm2 culture ﬂasks. Cells were
cultured in MEM/199medium (Invitrogen) containing 5 mM glucose,
10% horse serum, 10% fetal calf serum, 0.5% Ultroser G, antibiotics and
2 mM L-glutamine for myoblasts proliferation.
Cells were transfected with lipofectamin 2000 (Invitrogen). Six
hours after transfection, cells were placed in differentiation medium
for 48 h and RNA was extracted from transfected cells by the RNeasy
Fibrous Tissue kit (QIAGEN). RNA was reverse transcribed with the
Superscript III First-Strand Synthesis System (Invitrogen). The
number of PCR cycles was: ×27 for β actin ampliﬁcation; ×30 for
Eno3, Six1 and Six4; ×32 for myogenin, Myl1, Srl and Tnnt3; ×35 for
Atp2a1, Atp2a2, Iﬁtm3, Kcne1l, Tnni1, and Tnnt1.
Immunohistochemistry
For Desmin antibodies, embryos were ﬁxed in 4% PFA overnight at
4 °C. For other antibodies, embryos were ﬁxed in 0.2% PFA in 0.1 M
phosphate buffer (PB) with 0.12 mM CaCl2 and 4% sucrose overnightat 4 °C. Fixed embryos were washed twice in PBS (for Desmin
immunostaining) or PB for 10 min. Embryos were then incubated in
15% sucrose overnight at 4 °C before being frozen in -30 °C isopentane
and sectioned. To unmask antigens, transverse sections (12 μm) were
heated by microwave for 15 min in Retrievit™ solution (BioGenex).
After three washes in 1× PBS, slides were incubated in 1 PBS, 0.1%
triton X-100 for 20 min, blocked for 30 min in saturation solution (1×
PBS, 1% goat serum) and incubated with primary antibodies overnight
at 4 °C in saturation solution. Primary antibodies were rabbit
monoclonal anti-Desmin diluted 1/100 (Abcam, clone Y266), mouse
monoclonal anti-Myogenin diluted 1/50 (Dako, clone F5D), mouse
monoclonal anti-Atp2a1 diluted 1/100 (Ozyme), rabbit polyclonal
anti-Six1 diluted 1/400 (Sigma, prestige antibodies), rabbit anti-Six4
diluted 1/4000, rabbitmonoclonal anti-MyHCs diluted 1/5000 (Sigma,
M-8421), rabbit polyclonal anti-Troponin I1 slow diluted 1/50 (Santa
Cruz Biotechnology, H-51). After three washes in 1× PBS, slides were
incubated with secondary antibodies for 1 h at room temperature:
Alexa Fluor 488-conjugated goat anti-mouse IgG diluted 1/100, Alexa
Fluor 594-conjugated goat anti-rabbit IgG diluted 1/6000 (Molecular
Probes). Anti-rabbit Six1 and Six4 antibodies were detected with
Tyramide Signal Ampliﬁcation kit Alexa Fluor 555 (Molecular Probes).
Slideswere thenwashed in PBSbeforemounting in vectashield (Vector
Laboratories). Sections were photographed with a Zeiss Axiophot
microscope,with aNikon Eclipse E800 orwith a confocal LeicaDMIRE2.
Desmin and MyHCs staining areas were delineated manually and
calculated in μm2 with Lucia image software.Acknowledgments
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